The Samsung KODEX SYNTH-US Biotech ETF seeks long-term capital appreciation by tracking as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index
The Samsung KODEX SYNTH-US Biotech ETF (KRW) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The Samsung Asset fund’s base currency is KRW and the share class was registered 31.10.2013 with unique ISIN - KR7185680006. Main exchange is Korea Exchange and ticker symbol is 185680. The total expense ratio is 0.25%. The Samsung KODEX SYNTH-US Biotech ETF (KRW) pays dividends 0 time(s) per year.